haemoglobin a path i es

Upload: mahamud82

Post on 02-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/27/2019 Haemoglobin a Path i Es

    1/4

    Haemoglobin apathies

    Haemoglobin is the iron-containing oxygen-transport methlloprotein in the red blood cell of all

    vertebrates and the tissue of some vertebrates. Haemoglobin in blood is what transports oxygen

    from the lungs to the rest of the body where it releases the oxygen for cell use, and collects carbon

    dioxide to bring it back to the lungs.

    Haemoglobin has oxygen binding capacity which increases the total blood oxygen capacity.

    Haemoglobin is involved in the transport ofother gases: it carries some of the bodys respiratory

    carbon dioxide as carbaminoheamoglobi, in which CO2 is bound to the globin protein. The

    molecule also carries the important regulatory molecule nitric oxide bound to globin protein thiol

    group, releasing it at the same times as oxygen. Haemoglobin also found outside the red blood cells

    and their progenitor lines. Other cells that contain haemoglobin include macrophages, alveolar cells

    and mesangial cells in the kidney. In these tissues, haemoglobin has a non-oxygen-carrying

    function as an antioxidant and a regulatory of iron metabolism.

    Genetically haemoglobin consists of protein (the globin chain), and these proteins, in turn, are

    composed of sequences of amino acids. In all proteins, it is the variation in the type amino acids in

    the protein sequence of amino acids, which determines the proteins chemical properties and

    functions. The sequence of amino acids may affect crucial functions such as the proteins affinity

    oxygen. Mutations in the genes for the haemoglobin protein in a species result in haemoglobin

    variants. Many of these mutant forms of haemoglobin cause no disease. Some of these mutant

    forms of haemoglobin, cause a group of hereditary disease termed the

    HEAMOGLOBINOPATHIES. These disease known as SICKLE-CELL AND THALASSEMIA

    involves underproduction of

    In Case Synthesis haemoglobin is synthesized in a complex series of steps. Haemoglobin (HB) is

    tetramer of 4 globin chains each with own haem group. Each heam contains fe2+. The heam part is

    synthesized in series steps in the mitochondria and cytosol of immature red blood cells, while the

    globin protein parts are synthesized by ribosomes in the cytosol. Heam prosthetic group flat

    molecule located in a pocket in the globin chains. This pocket has many non-polar amino acids.

    Normal adult blood contains 3 types of Hb: Hb A= a2B2, Hb F =a2y2 and Hb a2= a2s2. Genes for

    globin chains occur in 2 clusters: chromosomes 16 and 11. Globin genes arranged in order they are

    expressed. A-globin gene is duplicated (a1 and a2). Both genes on each chromosome are active.

    B-globin expressed at low level in early foetal life. Increased production after birth; switch toadult Hb (a2b2). Largely replaces y chain 3-6 months after birth. A-globin - expressed in foetal life;

    production maintained.

    HAEMOGLOBINOPATHIES

    Haemoglobin abnormalities result from: synthesis of an abnormal Hb caused by amino acid

    substitution in a or b-globin.inherited, e.g. sickle cell anaemia (Hb SS)

    Reduced rate synthesis of normal a-or b-globin chains heterogeneous group of genetic disorders e.g

    a and b-thalassemias. Genetic defect of haemoglobin

  • 7/27/2019 Haemoglobin a Path i Es

    2/4

    Sickle cell disease (SCD)

    Sickle cell diseases is a group of haemoglobin disorder in which the sickle B-globin gene is

    inherited. In case of sickle cell anaemia, homozygous (HbSS) is the most common. Hb S (Hb a2B2

    S) is soluble and forms crystals when exposed to low O2 tension. Deoxygenating sickle

    haemoglobin polymerizes into long fibres each consists of seven intertwined double strands with

    cross-linking. The red cells sickle and may block different area of the microcirculation or large

    vessels cause infarcts of various organs. One in four West African, maintained at this level because

    of the protection against malaria that is afforded by the carrier state.

    Clinical Features

    Homozygous disease is the most common form of sickle cell anaemia. Its clinical features are of

    severe haemolytic anaemia punctuated by crises. Symptoms of anaemia are often mild in relation to

    severity of the anaemia. Hb S gives up oxygen to the tissue and can be relatively compared to Hb

    A.

    Clinical expression of Hb SS is very variable, some patient tend to have normal life free of crisis

    other develop severe crises in early childhood or as young adult and my die as result of crises

    such as vaso-occlusive, visceral, aplastic or haemolysis.

    Clinical features - Crises

    Painful vaso-occlusive crises is most frequenct and are precipitated by such factors as infection,

    acidosis, dehydration, deoxygenating. Infracts can occur in variety of organ s including the bones,

    lungs, spleen, brain , spinal cord.

    Visceral sequestration crises these are cause by sickling within organs and pooling blood. Present

    with enlarge spleen seen in infants, falling haemoglobin and abnormal pain. Attach tend to be

    recurrent and usually splenectomy my needed.

    Aplastic crises these occur as result of infection with parvovirus or from folate deficiency and

    characterised by sudden fall of haemoglobin and reticulocytes

    Haemolytic crises increase rate of haemolysis with fall haemoglobin and rise in reticulocytes and

    usually accompany with painful crisis. Other clinical features are ulcers of the low legs are common

    as result of vascular stasis and local ischemia. Spleen enlargement in infancy and earlier but later

    reduces in size due to infarcts (autosplenectomy). Pulmonary hypertensions are common and

    increase risk of death. A proliferative Retinopathy and priapism. Chronic liver damage may accurs

    through gallstone to microinfarcs. Pigment (bilirubin) gallstones are frequent. Kidneys vulnerable

    to infarcts of the medulla failure to conc urine aggravates dehydration and crisis Nocturnal

    enuresis (bedwetting) is common. Osteomyelitis (usually from Salmonella).

    Laboratory findings

    Blood film will show Sickle and target cells seen; Features of splenic atrophy (e.g. Howell-Jolly

    bodies).Hb low in cf symptoms of anaemia (6-9 g/dL). Screening tests for sickling are positive

  • 7/27/2019 Haemoglobin a Path i Es

    3/4

    when blood is deoxygenated (e.g. dithionate, Na2HPO4). Hb electrophoresis: no Hb A is

    detected.Hb F variable; usually 5-15%. Larger amounts normally associated with milder disorder.

    TREATMENT

    Prophylactic avoid factors known to precipitate crises specially dehydration, anoxia, infections,and cooling of the skin surface. Good nutrition, hygiene; folic acid (5mg weekly). Crises treat by

    rest, warmth, rehydration by oral fluids and or intravenous normal saline and antibiotics. Suitable

    drugs are paracetamol, opiates (e.g diamorphine and anti-inflammatories. Exchange transfusion

    my be needed if there is neurological damage, VS crisis, repeated painful crises.

    Hb S < 30% in severe cases >= 2 year after stroke. Hydroxyurea (15-20mg/kg) can increase HB F

    improves clinical course >=3 painful crises each year. Immunisation e.g pneumococcal,

    haemophilus, Meningococcal vaccines and regular oral penicillin (equivalent if allergic) for

    example hepatitis B vaccination as transfusions may be required.

    Blood transfusion sometimes given if there is severe anaemia with systems. The aim is to suppress

    Hb S production over months and years and treat iron overload. Particular care is need in pregnancy

    and anaesthesia. In pregnancy transfusions needed to increase Hb S level during, pre-delivery andminor operations. In the case of the anaesthesia recovery techniques much be used to avid

    hypoxemia or acidosis. Stem cell transplantationcan cure dieases. Reseach into other drugs and

    gene therapy to enhance the Hb F synthesis and to increase solubility of Hb S is taking place

  • 7/27/2019 Haemoglobin a Path i Es

    4/4